Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01DA012403 | U.S. NIH Grant/Contract | View source | |
| DPMCDA |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Drug Abuse (NIDA) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary objective of the proposed study is to evaluate the efficacy of tobacco abstinence-contingent voucher incentives versus non-tobacco abstinence-contingent incentives for reducing or eliminating tobacco use during pregnancy in methadone treated women. In addition, the impact that this intervention has in reducing the incidence and severity of methadone associated neonatal abstinence syndrome will also be examined.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| tobacco abstinent contingent voucher | Experimental | Tobacco abstinent contingent voucher condition |
|
| non-contingent | Experimental | Participants receive vouchers non-contingent upon tobacco use status |
|
| no voucher | Other | This is the standard care intervention |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| tobacco abstinent contingent | Behavioral | Participants receive vouchers wiht monetary rewards for providing breath samples that show tobacco smoking abstinence |
|
| Measure | Description | Time Frame |
|---|---|---|
| Percent of tobacco-free urine samples submitted and Neonatal Abstinence Score | from treatment entry until 6 weeks post-partum |
| Measure | Description | Time Frame |
|---|---|---|
| tobacco use measures • treatment compliance• Neonatal measures include:Birth parameters | from treatment entry to 6 weeks posrt-partum |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Hendree E Jones, PhD | Johns Hopkins University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Johns Hopkins Bayview Medical Center, Center for Addiction and Pregnancy | Baltimore | Maryland | 21224 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 22352784 | Derived | Tuten M, Svikis DS, Keyser-Marcus L, O'Grady KE, Jones HE. Lessons learned from a randomized trial of fixed and escalating contingency management schedules in opioid-dependent pregnant women. Am J Drug Alcohol Abuse. 2012 Jul;38(4):286-92. doi: 10.3109/00952990.2011.643977. Epub 2012 Feb 22. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014029 | Tobacco Use Disorder |
| D012907 | Smoking |
| D009357 | Neonatal Abstinence Syndrome |
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| non-contingent | Behavioral | Participants receive vouchers regardless of tobacco use status |
|
| control | Behavioral | this group receives no vouchers |
|
| D007232 |
| Infant, Newborn, Diseases |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |